Go Back ENT/22. Orbit/Neoplasm, Neoplasm-like condition/22.3 - Orbital Venolymphatic Malformation/ Go to Index

Case #1

History:

7 y.o. male with proptosis (painless)

Findings

Intraconal (primarily) and Extraconal

Lobulated margins

T1: hypointense

T2:

Very hyperintense fluid

Fluid-fluid levels

T1 post-Gd: enhancing septae

(No flow voids)

DDx

Irregular enhancing orbital mass in a child:

Capillary Hemangioma

Cavernous Hemangioma

Lymphangioma

Plexiform Neurofibroma

Orbital Pseudotumor

Rhabdomyosarcoma

Hematologic malignancy

Leukemia, Lymphoma

Langerhans cell histiocytosis

Diagnosis

Irregular enhancing orbital mass in a child:

Capillary Hemangioma

Cavernous Hemangioma

Lymphangioma

Plexiform Neurofibroma

Orbital Pseudotumor

Painful proptosis

Rhabdomyosarcoma

Hematologic malignancy

Leukemia, Lymphoma

Langerhans cell histiocytosis

Orbital Lymphangioma

Also known as:

Cystic hygroma

Orbital lymphatic-venous malformation

Infants, young adults

Usually presents in 1st decade

Slight female predominance

Orbital Lymphangioma

Pathology

Congenital, benign vascular tumor consisting of dilated vascular channels surrounded by lymphoid tissue

Etiology

Hamartoma from vascular mesenchymal anlage that develops with no systemic vascular or lymphatic connection

Orbital Lymphangioma

Epidemiology

3 in 100, 000

5% or childhood orbital tumors

8% of expanding orbital tumors

Less common than orbital

Capillary Hemangioma

Cavernous Hemangioma

Orbital Lymphangioma

Clinical

Progressive painless proptosis

Periorbital ecchymosis

Diplopia, ptosis, restricted EOM movement

Orbital Lymphangioma

Natural History, Prognosis

Continues to expand

Does not involute (like capillary hemangioma)

May intermittently increase in size with upper respiratory infection (lymphatic tissue)

May rapidly increase in size due to hemorrhage

Increased recurrence

Refractory visual problems and disfigurement are common

Poor visual acuity assoc. with multiple surgical resections

Orbital Lymphangioma

Treatment

Conservative

If vision not threatened

Systemic steroids

May decrease pain, swelling, and proptosis.

Surgery

50% recurrence

Subsequent visual impairment

May result in additional mass effect due to hemorrhage